Indication intelligence, analysis and sector perception

Precigen (PGEN) prices offering at $7.50 15 M share offering

January 22, 2021

PGEN closed down -$0.27 or -2.87% to $9.14 with a -$1.26 or -13.79% aftermarket indication Proceeds from the offering, are expected to be approximately $112.5 million, excluding any exercise of the underwriters' option. Wells Fargo Securities and Stifel are acting as joint book-running managers for the offering with JMP Securities acting as lead co-manager and H.C. Wainwright & Co. acting as co-manager.

Caladrius Biosciences (CLBS) proposes $25 M Private Placement of 12.5 M shares plus warrants at a purchase price of $2.00

January 21, 2021

CLBS has dropping -$0.40 or -13.84% to $2.485 The warrants have an exercise price of $2.90 per share, are exercisable immediately and have a term of five and one-half years.  

Editas Medicine (EDIT) proposes 3.5 million shares offering

January 19, 2021

EDIT closed down -$4.03 or -5.29% to $72.11 and has a negative -$1.11 or -1.54% aftermarket indication, so far J.P. Morgan and Morgan Stanley are acting as joint book-running managers for the offering. Cowen and Credit Suisse are acting as book-runners.